ストックスクリーナーアプリを入手
3.10
12.80%
-0.455
前日終値:
$3.555
開ける：
$3.46
24時間の取引高:
14,267
Relative Volume:
1.34
時価総額：
$4.61M
収益：
$27.40M
当期純損益:
$-17.12M
株価収益率:
-0.029
EPS:
-106.8896
ネットキャッシュフロー:
$-24.99M
1週間 パフォーマンス:
-22.31%
1か月 パフォーマンス:
-1.90%
6か月 パフォーマンス:
-1.27%
1年 パフォーマンス:
-74.97%
1日の値動き範囲:
$3.02
$3.48
1週間の範囲:
$3.02
$3.82
52週間の値動き範囲:
$2.5211
$16.97
Dna X Inc Stock (SONM) Company Profile
Compare SONM vs MS, GS, SCHW, HOOD, IBKR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.10 | 4.61M | 27.40M | -17.12M | -24.99M | -106.89 |
MS
Morgan Stanley
|
186.64 | 293.13B | 128.77B | 20.37B | 39.02B | 12.37 |
GS
Goldman Sachs Group Inc
|
891.91 | 259.70B | 128.57B | 20.97B | 112.72B | 64.79 |
SCHW
Charles Schwab Corp
|
95.94 | 165.91B | 28.33B | 9.42B | 9.76B | 5.0426 |
HOOD
Robinhood Markets Inc
|
110.52 | 99.37B | 4.65B | 1.89B | -2.09B | 2.0676 |
IBKR
Interactive Brokers Group Inc
|
87.49 | 39.64B | 10.76B | 4.56B | 35.82B | 2.326 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-10-31 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-07-18 | 開始されました | B. Riley FBR | Buy |
| 2019-07-09 | アップグレード | National Securities | Neutral → Buy |
| 2019-06-10 | 開始されました | National Securities | Neutral |
| 2019-06-04 | 開始されました | Lake Street | Buy |
| 2019-06-04 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Dna X Inc (SONM) 最新ニュース
A planned share sale leaves Ginkgo Bioworks (DNA) CFO holding 49,448 shares directly. - Stock Titan
Applied DNA Sciences, Inc. (OTC: BNBX) Share Price, BNBX Stock News, BNBX Share Price & Updates - Kalkine
AIxCrypto Holdings, Inc. (AIXC) stock price, news, quote and history - Yahoo Finance UK
Scribe Therapeutics Inc. Common Stock (NASDAQ: SCTX) Stock Price, News & Analysis - kalkine.ca
VEON Ltd. (VEON) stock price, news, quote and history - uk.finance.yahoo.com
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance Singapore
Ginkgo Bioworks (NYSE: DNA) director sells 5,000 shares near $7.08 - Stock Titan
Director plans potential 5,000-share sale at Ginkgo Bioworks (NYSE: DNA) - Stock Titan
Ginkgo Bioworks Holdings (NYSE:DNA) Stock Forecast & Analyst Predictions - Simply Wall Street
Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News
Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail
DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Management Guidance Update - careplusvn.com
Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail
DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView
DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan
Ginkgo Bioworks (DNA) CFO logs 743 RSU vesting, tax sale - Stock Titan
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView
DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan
DNA X: Q2 Earnings Snapshot - marketscreener.com
DNA X: Q2 Earnings Snapshot - AOL.com
DNA X: Q2 Earnings Snapshot - KTVB
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
C&F Financial Corporation Announces Quarterly Dividend - The Manila Times
Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times
VVC Exploration Corporation Files Annual Financial Statements - The Manila Times
DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan
DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn
DNA X Inc: Expects Revenue From Trading Platf - Moomoo
DNA X, Inc. Reports Second Quarter 2026 Financial Results - Yahoo Finance
12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga
Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - vinanet.vn
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st
Sonim Technologies delays quarterly filing amid consolidation - TipRanks
DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
META_TITLE_QUOTE - Yahoo Finance
DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan
DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan
DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - vinanet.vn
DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsVolume Breakout Ideas - dars.gov.et
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance
Star Wars Zero Company is a very safe XCOM descendant, but its most interesting parts are found in its Midnight Suns DNA - PC Gamer
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesPost-Announcement Reaction - vinanet.vn
Dna X Inc (SONM) 財務データ
収益
当期純利益
現金流量
EPS
3.29%
16.39%
大文字化:
|
ボリューム (24 時間):